2021

1. Bip heterozigosity aggravates pathological deterioration in experimental amyotrophic lateral sclerosis

   International Journal of Molecular Sciences, Vol. 22, Núm. 22

2. Inactivation of the CB2 receptor accelerated the neuropathological deterioration in TDP-43 transgenic mice, a model of amyotrophic lateral sclerosis

   Brain Pathology, Vol. 31, Núm. 6

3. Preclinical investigation in neuroprotective effects of the gpr55 Ligand VCE-006.1 in experimental models of Parkinson’s disease and amyotrophic lateral sclerosis

   Molecules, Vol. 26, Núm. 24

4. Targeting the CB2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis

   British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1373-1387